Figure 1.

Mean (SD) serum brodalumab concentration × time profiles (semilog) in rheumatoid arthritis patients following (A) repeat subcutaneous administration and (B) repeat intravenous administration. IV, intravenous; SC, subcutaneous.

Martin et al. Arthritis Research & Therapy 2013 15:R164   doi:10.1186/ar4347
Download authors' original image